<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Ifosfamid.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:59 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="filelist-277.xml.html" tppabs="http://www.vietstarse.com/duocthu/Documents/Ifosfamid_files/filelist.xml">
<link rel=Edit-Time-Data href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Ifosfamid_files/editdata.mso  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Ifosfamid_files/editdata.mso'" tppabs="http://www.vietstarse.com/duocthu/Documents/Ifosfamid_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title>IFOSFAMID</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VS35</o:Author>
  <o:LastAuthor>Ghost</o:LastAuthor>
  <o:Revision>3</o:Revision>
  <o:TotalTime>3</o:TotalTime>
  <o:Created>2006-08-08T14:06:00Z</o:Created>
  <o:LastSaved>2006-08-08T14:25:00Z</o:LastSaved>
  <o:Pages>4</o:Pages>
  <o:Words>1430</o:Words>
  <o:Characters>8152</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>67</o:Lines>
  <o:Paragraphs>19</o:Paragraphs>
  <o:CharactersWithSpaces>9563</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	page-break-before:always;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:12.0pt;
	font-family:Tahoma;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
	{margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1027"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana'>IFOSFAMID<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tên chung qu&#7889;c t&#7871;:</span></b><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'> Ifosfamide.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Mã ATC:</span></b><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'> L01A A06.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Lo&#7841;i thu&#7889;c:</span></b><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'> Thu&#7889;c ch&#7889;ng
ung th&#432;, ch&#7845;t alkyl hóa; mù t&#7841;c nitrogen.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>D&#7841;ng thu&#7889;c và hàm
l&#432;&#7907;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Ifosfamid tiêm &#273;&#432;&#7907;c &#273;óng t&#7915;ng
li&#7873;u trong các l&#7885; &#273;&#7875; pha dung d&#7883;ch tiêm truy&#7873;n
t&#297;nh m&#7841;ch, m&#7895;i l&#7885; ch&#7913;a 1 gam ho&#7863;c 3 gam b&#7897;t
ifosfamid vô khu&#7849;n.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Thu&#7889;c &#273;&#432;&#7907;c cung c&#7845;p trong m&#7897;t ki&#7879;n
&#273;óng gói ph&#7889;i h&#7907;p v&#7899;i thu&#7889;c b&#7843;o v&#7879;
&#273;&#432;&#7901;ng ti&#7871;t ni&#7879;u mesna tiêm.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c lý và c&#417; ch&#7871;
tác d&#7909;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ifosfamid là m&#7897;t d&#7851;n ch&#7845;t oxazaphosphorin
t&#432;&#417;ng t&#7921; c&#7911;a cyclophosphamid, và gi&#7889;ng nh&#432;
cyclophosphamid, ifosfamid &#273;&#432;&#7907;c các enzym &#7903; microsom gan
xúc tác &#273;&#7875; chuy&#7875;n hóa t&#7841;o thành nh&#7919;ng ch&#7845;t
có ho&#7841;t tính sinh h&#7885;c. Nh&#7919;ng ch&#7845;t chuy&#7875;n hóa c&#7911;a
ifosfamid t&#432;&#417;ng tác và liên k&#7871;t &#273;&#7891;ng hóa tr&#7883; v&#7899;i
các base c&#7911;a DNA. T&#7889;c &#273;&#7897; chuy&#7875;n hóa ifosfamid &#7903;
gan thành ch&#7845;t chuy&#7875;n hóa có ho&#7841;t tính 4 - hydroxy ifosfamid
h&#417;i ch&#7853;m h&#417;n so v&#7899;i cyclophosphamid, m&#7863;c dù s&#7921;
t&#7841;o thành acrolein, &#273;&#7897;c v&#7899;i bàng quang, không gi&#7843;m.
S&#7921; khác nhau v&#7873; chuy&#7875;n hóa có th&#7875; gi&#7843;i thích
ifosfamid ph&#7843;i cho li&#7873;u cao h&#417;n cyclophosphamid &#273;&#7875;
có m&#7897;t tác d&#7909;ng &#273;&#7897;c t&#7871; bào b&#7857;ng nhau và gi&#7843;i
thích s&#7921; khác nhau có th&#7875; có v&#7873; ph&#7893; tác d&#7909;ng c&#7911;a
chúng &#273;&#7889;i v&#7899;i các u. Ch&#7845;t chuy&#7875;n hóa cu&#7889;i
cùng c&#7911;a ifosfamid liên k&#7871;t chéo v&#7899;i DNA và làm suy gi&#7843;m
s&#7921; phân chia t&#7871; bào, b&#7857;ng cách liên k&#7871;t v&#7899;i acid
nucleic và v&#7899;i nh&#7919;ng c&#7845;u trúc khác trong t&#7871; bào.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Do t&#7841;o nên acrolein và nh&#7919;ng ch&#7845;t chuy&#7875;n hóa
gây ph&#7843;n &#7913;ng khác, ifosfamid luôn &#273;&#432;&#7907;c dùng v&#7899;i
mesna, &#273;&#7875; d&#7921; phòng tác d&#7909;ng &#273;&#7897;c t&#7841;i
&#273;&#432;&#7901;ng ti&#7871;t ni&#7879;u. Hi&#7879;n nay, ifosfamid
&#273;&#432;&#7907;c dùng ph&#7889;i h&#7907;p v&#7899;i nh&#7919;ng thu&#7889;c
khác &#273;&#7875; &#273;i&#7873;u tr&#7883; ung th&#432; t&#7871; bào m&#7847;m
tinh hoàn và &#273;&#432;&#7907;c dùng r&#7897;ng rãi &#273;&#7875; &#273;i&#7873;u
tr&#7883; sarcom &#7903; tr&#7867; em và ng&#432;&#7901;i l&#7899;n. Nh&#7919;ng
th&#7917; nghi&#7879;m lâm sàng &#273;ã ch&#7913;ng minh ifosfamid có tác d&#7909;ng
&#273;&#7889;i v&#7899;i ung th&#432; bi&#7875;u mô c&#7893; t&#7917; cung, ph&#7893;i,
và &#273;&#7889;i v&#7899;i u lympho. Nó là m&#7897;t thành ph&#7847;n th&#432;&#7901;ng
dùng trong nh&#7919;ng phác &#273;&#7891; hóa tr&#7883; li&#7879;u li&#7873;u
cao.<o:p></o:p></span></p>

<p class=5 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>D&#432;&#7907;c &#273;&#7897;ng h&#7885;c<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ifosfamid có n&#7917;a &#273;&#7901;i trong huy&#7871;t
t&#432;&#417;ng x&#7845;p x&#7881; 15 gi&#7901; sau khi dùng nh&#7919;ng li&#7873;u
t&#7915; 3,8 &#273;&#7871;n 5,0 g/m<sup>2</sup> và n&#7917;a &#273;&#7901;i
h&#417;i ng&#7855;n h&#417;n v&#7899;i nh&#7919;ng li&#7873;u th&#7845;p
h&#417;n. D&#432;&#7907;c &#273;&#7897;ng h&#7885;c ph&#7909; thu&#7897;c vào
li&#7873;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Ifosfamid và các ch&#7845;t chuy&#7875;n hóa
&#273;&#432;&#7907;c phân b&#7889; kh&#7855;p c&#417; th&#7875;, k&#7875; c&#7843;
não và d&#7883;ch não t&#7911;y. Ifosfamid &#273;&#432;&#7907;c chuy&#7875;n
hóa thành ch&#7845;t alkyl</span><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'> hóa có ho&#7841;t tính, mù t&#7841;c
ifosforamid do enzym cytochrom P<sub>450 </sub>2B6, &#273;ã bi&#7871;n &#273;&#7893;i
ifosfamid thành 4 - hydroxy ifosfamid (có tác d&#7909;ng là d&#7841;ng chuy&#7875;n
v&#7853;n c&#7911;a phân t&#7917;). Sau &#273;ó ch&#7845;t chuy&#7875;n hóa 4 -
hydroxy &#273;&#432;&#7907;c chuy&#7875;n thành nh&#7919;ng ch&#7845;t chuy&#7875;n
hóa có ho&#7841;t tính và không có ho&#7841;t tính, do ph&#7843;n &#7913;ng hóa
h&#7885;c ho&#7863;c enzym. Nh&#7919;ng ch&#7845;t chuy&#7875;n hóa không có ho&#7841;t
tính g&#7891;m 4 - carboxy ifosfamid và nhi&#7873;u ch&#7845;t decloroethyl hóa
nh&#432; acid thiodiacetic. Kho&#7843;ng 60 - 80% các li&#7873;u thu&#7889;c
&#273;&#432;&#7907;c bài ti&#7871;t vào n&#432;&#7899;c ti&#7875;u trong 72 gi&#7901;,
trong &#273;ó có t&#7899;i 50% là thu&#7889;c không bi&#7871;n &#273;&#7893;i.
Cùng v&#7899;i 4 - hydroxy ifosfamid, ch&#7845;t acrolein gây kích &#7913;ng
bàng quang c&#361;ng &#273;&#432;&#7907;c bài ti&#7871;t qua th&#7853;n và có
th&#7875; tích l&#361;y t&#7899;i n&#7891;ng &#273;&#7897; cao trong bàng
quang.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ifosfamid, dùng ph&#7889;i h&#7907;p v&#7899;i m&#7897;t s&#7889; thu&#7889;c
ch&#7889;ng ung th&#432; khác &#273;ã &#273;&#432;&#7907;c ch&#7845;p thu&#7853;n,
&#273;&#432;&#7907;c ch&#7881; &#273;&#7883;nh trong li&#7879;u pháp hóa h&#7885;c
hàng th&#7913; ba &#273;&#7889;i v&#7899;i nh&#7919;ng b&#7879;nh sau:<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>B&#7879;nh b&#7841;ch c&#7847;u th&#7875; lympho c&#7845;p tính và m&#7841;n
tính.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>B&#7879;nh Hodgkin và các u lympho không Hodgkin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ða u t&#7911;y.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>U nguyên bào th&#7847;n kinh.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Các kh&#7889;i u vú, bu&#7891;ng tr&#7913;ng, ph&#7893;i, u Wilms.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Các sarcom c&#7893; t&#7917; cung, tinh hoàn và mô m&#7873;m.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Bao gi&#7901; c&#361;ng dùng ifosfamid ph&#7889;i h&#7907;p v&#7899;i
m&#7897;t thu&#7889;c d&#7921; phòng viêm bàng quang ch&#7843;y máu, nh&#432;
mesna.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ch&#7889;ng ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ðã có m&#7851;n c&#7843;m v&#7899;i ifosfamid.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Dùng liên t&#7909;c ifosfamid cho ng&#432;&#7901;i suy ch&#7913;c
n&#259;ng t&#7911;y x&#432;&#417;ng n&#7863;ng (b&#7841;ch c&#7847;u d&#432;&#7899;i
2000/mm<sup>3</sup> và/ho&#7863;c ti&#7875;u c&#7847;u d&#432;&#7899;i
50.000/mm<sup>3</sup>).<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7853;n tr&#7885;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>H&#7879; ti&#7871;t ni&#7879;u</span></i><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>: Nh&#7919;ng
tác d&#7909;ng &#273;&#7897;c h&#7841;i &#7903; &#273;&#432;&#7901;ng ti&#7871;t
ni&#7879;u, &#273;&#7863;c bi&#7879;t viêm bàng quang ch&#7843;y máu, th&#432;&#7901;ng
g&#7863;p khi s&#7917; d&#7909;ng ifosfamid. Nên xét nghi&#7879;m n&#432;&#7899;c
ti&#7875;u tr&#432;&#7899;c m&#7895;i l&#7847;n dùng ifosfamid.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>N&#7871;u th&#7845;y có huy&#7871;t - ni&#7879;u vi th&#7875;, thì ng&#7915;ng
dùng thu&#7889;c cho t&#7899;i khi kh&#7887;i hoàn toàn. Sau &#273;ó, dùng ti&#7871;p
ifosfamid &#273;&#7891;ng th&#7901;i u&#7889;ng nhi&#7873;u n&#432;&#7899;c ho&#7863;c
truy&#7873;n d&#7883;ch. Th&#7853;n tr&#7885;ng v&#7899;i ng&#432;&#7901;i có
ch&#7913;c n&#259;ng th&#7853;n gi&#7843;m.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>H&#7879; t&#7841;o máu</span></i><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>: Khi dùng
ifosfamid ph&#7889;i h&#7907;p v&#7899;i nh&#7919;ng thu&#7889;c hóa tr&#7883;
li&#7879;u khác, th&#432;&#7901;ng th&#7845;y suy t&#7911;y nghiêm tr&#7885;ng.
C&#7847;n theo dõi ch&#7863;t ch&#7869; v&#7873; huy&#7871;t h&#7885;c. Xét
nghi&#7879;m b&#7841;ch c&#7847;u, ti&#7875;u c&#7847;u và hemoglobin tr&#432;&#7899;c
m&#7895;i l&#7847;n dùng thu&#7889;c và &#7903; nh&#7919;ng kho&#7843;ng cách
th&#7901;i gian thích h&#7907;p.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:.1pt'>Tr&#7915; khi c&#7847;n thi&#7871;t v&#7873; m&#7863;t
lâm sàng, không nên dùng ifosfamid cho ng&#432;&#7901;i có s&#7889; l&#432;&#7907;ng
b&#7841;ch c&#7847;u d&#432;&#7899;i 2.000/mm<sup>3</sup> và/ho&#7863;c s&#7889;
l&#432;&#7907;ng ti&#7875;u c&#7847;u d&#432;&#7899;i 50.000/mm<sup>3</sup>.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i k&#7923; mang thai<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ifosfamid có th&#7875; gây &#273;&#7897;t bi&#7871;n gen và t&#7893;n
h&#7841;i nhi&#7877;m s&#7855;c th&#7875;. Ðã nh&#7853;n th&#7845;y tác d&#7909;ng
&#273;&#7897;c &#273;&#7889;i v&#7899;i phôi và tác d&#7909;ng sinh quái thai.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ifosfamid có th&#7875; gây t&#7893;n h&#7841;i &#273;&#7889;i v&#7899;i
thai khi dùng cho ng&#432;&#7901;i mang thai. N&#7871;u dùng ifosfamid trong th&#7901;i
k&#7923; mang thai, ho&#7863;c ng&#432;&#7901;i b&#7879;nh th&#7909; thai khi
&#273;ang dùng thu&#7889;c này, thì ph&#7843;i thông báo cho ng&#432;&#7901;i b&#7879;nh
v&#7873; s&#7921; nguy h&#7841;i có th&#7875; x&#7843;y ra &#273;&#7889;i v&#7899;i
thai.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i k&#7923; cho con bú<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ifosfamid &#273;&#432;&#7907;c bài ti&#7871;t trong s&#7919;a m&#7865;.
Do ifosfamid có th&#7875; có nh&#7919;ng tác d&#7909;ng không mong mu&#7889;n
nghiêm tr&#7885;ng và có tác d&#7909;ng gây ung th&#432;, nên ph&#7843;i ng&#7915;ng
cho con bú trong th&#7901;i gian dùng thu&#7889;c.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Tác d&#7909;ng không mong mu&#7889;n
(ADR)<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ifosfamid &#7913;c ch&#7871; t&#7911;y x&#432;&#417;ng và &#273;&#7897;c
v&#7899;i &#273;&#432;&#7901;ng ti&#7871;t ni&#7879;u. Thu&#7889;c có tính ch&#7845;t
&#273;&#7897;c h&#7841;i th&#7847;n kinh nhi&#7873;u nh&#7845;t trong s&#7889;
các thu&#7889;c alkyl hóa, và có kh&#7843; n&#259;ng gây ung th&#432; th&#7913;
phát.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Th&#432;&#7901;ng g&#7863;p, ADR &gt; 1/100</span></i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'><o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Th&#7847;n kinh trung &#432;&#417;ng: Ng&#7911; gà, lú l&#7851;n, &#7843;o
giác (th&#432;&#7901;ng h&#7891;i ph&#7909;c và th&#432;&#7901;ng x&#7843;y ra
v&#7899;i li&#7873;u cao ho&#7863;c &#7903; ng&#432;&#7901;i có suy gi&#7843;m
ch&#7913;c n&#259;ng th&#7853;n); lo&#7841;n th&#7847;n, tr&#7847;m c&#7843;m.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tiêu hóa: Bu&#7891;n nôn và nôn (&#7903; 58% s&#7889; ng&#432;&#7901;i
b&#7879;nh, th&#432;&#7901;ng g&#7863;p h&#417;n v&#7899;i li&#7873;u cao, có
th&#7875; kéo dài &#273;&#7871;n 3 ngày sau &#273;i&#7873;u tr&#7883;).<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Sinh d&#7909;c - ti&#7871;t ni&#7879;u: Viêm bàng quang ch&#7843;y
máu.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Chuy&#7875;n hóa: Nhi&#7877;m toan chuy&#7875;n hóa (t&#7899;i 31%)<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Da: R&#7909;ng tóc (&#7903; 50% &#273;&#7871;n 80%), viêm t&#297;nh m&#7841;ch,
viêm da, t&#259;ng s&#7855;c t&#7889; da, ch&#7853;m lành v&#7871;t
th&#432;&#417;ng.<o:p></o:p></span></p>

<p class=5 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;font-style:normal'>Huy&#7871;t h&#7885;c:</span><span style='font-size:
9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'> </span><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;font-style:normal'>Suy t&#7911;y.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Gan: T&#259;ng các enzym gan.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Hô h&#7845;p: Sung huy&#7871;t m&#361;i, x&#417; hóa ph&#7893;i.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Khác: Suy gi&#7843;m mi&#7877;n d&#7883;ch, vô sinh, có th&#7875; b&#7883;
ph&#7843;n &#7913;ng d&#7883; &#7913;ng, ung th&#432; th&#7913; phát.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ít g&#7863;p, 1/1000 &lt; ADR &lt; 1/100 <o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Th&#7847;n kinh trung &#432;&#417;ng: B&#7879;nh &#273;a dây th&#7847;n
kinh.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tim m&#7841;ch: Tác d&#7909;ng &#273;&#7897;c h&#7841;i tim.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Da: Viêm da.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tiêu hóa: Chán &#259;n, táo bón, &#7881;a ch&#7843;y, ti&#7871;t
n&#432;&#7899;c b&#7885;t, viêm mi&#7879;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Hô h&#7845;p: Nh&#7919;ng tri&#7879;u ch&#7913;ng v&#7873; ph&#7893;i
(ho ho&#7863;c th&#7903; ng&#7855;n h&#417;i).<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Huy&#7871;t h&#7885;c: B&#7879;nh do r&#7889;i lo&#7841;n &#273;ông
máu.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Khác: M&#7879;t m&#7887;i, khó ch&#7883;u.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>H&#432;&#7899;ng d&#7851;n cách x&#7917;
trí ADR<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ifosfamid luôn &#273;&#432;&#7907;c dùng v&#7899;i mesna &#273;&#7875;
d&#7921; phòng tác d&#7909;ng &#273;&#7897;c &#7903; &#273;&#432;&#7901;ng ti&#7871;t
ni&#7879;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ph&#7843;i dùng ifosfamid th&#7853;n tr&#7885;ng &#7903; ng&#432;&#7901;i
b&#7879;nh b&#7883; suy gi&#7843;m ch&#7913;c n&#259;ng th&#7853;n và &#7903;
ng&#432;&#7901;i có t&#7911;y x&#432;&#417;ng b&#7883; t&#7893;n h&#7841;i,
nh&#432; gi&#7843;m b&#7841;ch c&#7847;u, gi&#7843;m b&#7841;ch c&#7847;u h&#7841;t,
nh&#7919;ng di c&#259;n r&#7897;ng &#7903; t&#7911;y x&#432;&#417;ng, tr&#432;&#7899;c
&#273;ó &#273;ã &#273;i&#7873;u tr&#7883; chi&#7871;u tia x&#7841; ho&#7863;c
&#273;ã dùng nh&#7919;ng thu&#7889;c &#273;&#7897;c h&#7841;i t&#7871; bào
khác.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Khi x&#7843;y ra nh&#7919;ng tri&#7879;u ch&#7913;ng th&#7847;n kinh,
ph&#7843;i ng&#7915;ng dùng ifosfamid và &#273;i&#7873;u tr&#7883; h&#7895; tr&#7907;
cho &#273;&#7871;n khi kh&#7887;i hoàn toàn các tri&#7879;u ch&#7913;ng này.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Vi&#7879;c chia thu&#7889;c thành nh&#7919;ng li&#7873;u nh&#7887;, ti&#7871;p
nhi&#7873;u n&#432;&#7899;c và dùng thu&#7889;c b&#7843;o v&#7879; nh&#432;
mesna có th&#7875; làm gi&#7843;m &#273;áng k&#7875; t&#7927; l&#7879; &#273;ái
ra máu, &#273;&#7863;c bi&#7879;t &#273;ái ra máu n&#7863;ng, k&#7871;t h&#7907;p
v&#7899;i viêm bàng quang ch&#7843;y máu.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Khi dùng ifosfamid k&#7871;t h&#7907;p v&#7899;i nh&#7919;ng thu&#7889;c
suy gi&#7843;m t&#7911;y khác, c&#7847;n &#273;i&#7873;u ch&#7881;nh li&#7873;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Có th&#7875; &#273;i&#7873;u tr&#7883; bu&#7891;n nôn và nôn b&#7857;ng
thu&#7889;c ch&#7889;ng nôn.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u l&#432;&#7907;ng và
cách dùng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ng&#432;&#7901;i l&#7899;n</span></i><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>: Nên dùng
ifosfamid b&#7857;ng cách tiêm truy&#7873;n t&#297;nh m&#7841;ch ch&#7853;m
trong t&#7889;i thi&#7875;u 30 phút, v&#7899;i li&#7873;u 1,2 g/m<sup>2</sup> m&#7895;i
ngày ho&#7863;c 50 mg/kg/ngày, trong 5 ngày li&#7873;n. Chu k&#7923; &#273;i&#7873;u
tr&#7883; th&#432;&#7901;ng &#273;&#432;&#7907;c nh&#7855;c l&#7841;i c&#7913;
3 - 4 tu&#7847;n m&#7897;t &#273;&#7907;t ho&#7863;c sau khi h&#7891;i ph&#7909;c
kh&#7887;i &#273;&#7897;c tính v&#7873; huy&#7871;t h&#7885;c (ti&#7875;u c&#7847;u
100.000 microlít, b&#7841;ch c&#7847;u 4.000 microlít).<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ð&#7875; d&#7921; phòng tác d&#7909;ng &#273;&#7897;c v&#7899;i bàng
quang, ph&#7843;i dùng ifosfamid kèm v&#7899;i b&#7891;i ph&#7909; nhi&#7873;u
n&#432;&#7899;c, t&#7889;i thi&#7875;u 2 lít d&#7883;ch u&#7889;ng ho&#7863;c
tiêm truy&#7873;n t&#297;nh m&#7841;ch m&#7895;i ngày. Dùng m&#7897;t thu&#7889;c
b&#7843;o v&#7879; nh&#432; mesna, &#273;&#7875; phòng viêm bàng quang ch&#7843;y
máu. Tiêm t&#297;nh m&#7841;ch mesna &#273;&#7891;ng th&#7901;i v&#7899;i
ifosfamid v&#7899;i li&#7873;u b&#7857;ng 20% li&#7873;u ifosfamid và tiêm l&#7841;i
li&#7873;u &#273;ó sau 4 và 8 gi&#7901;, &#273;&#7875; có t&#7893;ng li&#7873;u
mesna b&#7857;ng 60% li&#7873;u ifosfamid.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ng&#432;&#7901;i cao tu&#7893;i</span></i><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>: Li&#7873;u
cho ng&#432;&#7901;i cao tu&#7893;i c&#361;ng gi&#7889;ng nh&#432; cho ng&#432;&#7901;i
l&#7899;n, nh&#432;ng &#273;i&#7873;u ch&#7881;nh cho phù h&#7907;p v&#7899;i
ch&#7913;c n&#259;ng th&#7853;n b&#7883; suy gi&#7843;m do tu&#7893;i.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tr&#7867; em</span></i><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>: 1,2 g/m<sup>2</sup>/ngày, tiêm
truy&#7873;n t&#297;nh m&#7841;ch ch&#7853;m trong 30 phút, trong 3 - 5 ngày, c&#7913;
3 - 4 tu&#7847;n m&#7897;t &#273;&#7907;t, cùng v&#7899;i thu&#7889;c b&#7843;o
v&#7879; mesna.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ng&#432;&#7901;i có t&#7893;n th&#432;&#417;ng th&#7853;n:<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Creatinin huy&#7871;t thanh trên 3,0 mg/decilit: Không dùng thu&#7889;c.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Creatinin huy&#7871;t thanh 2,1 - 3 mg/decilit: Gi&#7843;m li&#7873;u
25% - 50%.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ng&#432;&#7901;i có t&#7893;n th&#432;&#417;ng gan:</span></i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'> Ch&#432;a có h&#432;&#7899;ng d&#7851;n &#273;&#7863;c bi&#7879;t.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Pha thu&#7889;c tiêm truy&#7873;n t&#297;nh m&#7841;ch</span></i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>:<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Pha thu&#7889;c &#273;&#7875; tiêm b&#7857;ng cách cho thêm n&#432;&#7899;c
c&#7845;t vô khu&#7849;n vào l&#7885; &#273;&#7921;ng ifosfamid và l&#7855;c
&#273;&#7875; hòa tan. Dùng l&#432;&#7907;ng ch&#7845;t pha loãng trình bày
d&#432;&#7899;i &#273;ây &#273;&#7875; pha thu&#7889;c:<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><!--[if gte vml 1]><o:wrapblock><v:shapetype
  id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
  path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
  <v:stroke joinstyle="miter"/>
  <v:formulas>
   <v:f eqn="if lineDrawn pixelLineWidth 0"/>
   <v:f eqn="sum @0 1 0"/>
   <v:f eqn="sum 0 0 @1"/>
   <v:f eqn="prod @2 1 2"/>
   <v:f eqn="prod @3 21600 pixelWidth"/>
   <v:f eqn="prod @3 21600 pixelHeight"/>
   <v:f eqn="sum @0 0 1"/>
   <v:f eqn="prod @6 1 2"/>
   <v:f eqn="prod @7 21600 pixelWidth"/>
   <v:f eqn="sum @8 21600 0"/>
   <v:f eqn="prod @7 21600 pixelHeight"/>
   <v:f eqn="sum @10 21600 0"/>
  </v:formulas>
  <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
  <o:lock v:ext="edit" aspectratio="t"/>
 </v:shapetype><v:shape id="_x0000_s1026" type="#_x0000_t75" style='position:absolute;
  margin-left:27pt;margin-top:0;width:211.5pt;height:51pt;z-index:1'>
  <v:imagedata src="Ifosfamid_files/image001.png" o:title=""/>
  <w:wrap type="topAndBottom"/>
 </v:shape><![endif]--><![if !vml]><span style='mso-ignore:vglayout'>
 <table cellpadding=0 cellspacing=0 align=left>
  <tr>
   <td width=36 height=0></td>
  </tr>
  <tr>
   <td></td>
   <td><img width=282 height=68 src="image003-6.gif" tppabs="http://www.vietstarse.com/duocthu/Documents/Ifosfamid_files/image003.gif" v:shapes="_x0000_s1026"></td>
  </tr>
 </table>
 </span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'><o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Có th&#7875; pha loãng ti&#7871;p nh&#7919;ng dung d&#7883;ch
ifosfamid &#273;&#7875; &#273;&#7841;t n&#7891;ng &#273;&#7897; t&#7915; 0,6
&#273;&#7871;n 20 mg/ml trong d&#7883;ch: Dextrose 5% lo&#7841;i tiêm; ho&#7863;c
natri clorid 0,9% lo&#7841;i tiêm; ho&#7863;c Ringer lactat lo&#7841;i tiêm;
n&#432;&#7899;c c&#7845;t vô khu&#7849;n &#273;&#7875; tiêm.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>C&#7847;n ki&#7875;m tra b&#7857;ng m&#7855;t th&#432;&#7901;ng xem có
ch&#7845;t v&#7849;n và bi&#7871;n màu trong các ch&#7871; ph&#7849;m thu&#7889;c
tr&#432;&#7899;c khi dùng.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng tác thu&#7889;c<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Vì các enzym c&#7911;a microsom (cytochrom P<sub>450</sub> 2B6,
cytochrom P<sub>450</sub> 2C, và cytochrom P<sub>450</sub> 3A) gây ho&#7841;t
hóa ifosfamid &#7903; gan, s&#7921; c&#7843;m &#7913;ng các enzym này có th&#7875;
x&#7843;y ra khi ng&#432;&#7901;i b&#7879;nh &#273;&#432;&#7907;c &#273;i&#7873;u
tr&#7883; tr&#432;&#7899;c v&#7899;i nh&#7919;ng thu&#7889;c gây c&#7843;m &#7913;ng
enzym nh&#432; phenobarbital, phenytoin và cloral hydrat.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>S&#7917; d&#7909;ng cùng v&#7899;i cisplatin có th&#7875; làm
t&#259;ng &#273;&#7897;c tính v&#7899;i th&#7853;n và m&#7845;t kali, magnesi,
&#273;&#7863;c bi&#7879;t &#7903; tr&#7867; em. Ð&#7897;c tính v&#7899;i th&#7853;n
c&#361;ng t&#259;ng lên khi dùng ph&#7889;i h&#7907;p ifosfamid v&#7899;i các
thu&#7889;c khác c&#361;ng &#273;&#7897;c h&#7841;i v&#7899;i th&#7853;n.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ð&#7897; &#7893;n &#273;&#7883;nh
và b&#7843;o qu&#7843;n<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>B&#7843;o qu&#7843;n ifosfamid &#7903; nhi&#7879;t &#273;&#7897; phòng
t&#7915; 20 &#273;&#7871;n 25<sup>O</sup>C. Tránh nhi&#7879;t &#273;&#7897;
trên 30<sup>O</sup>C.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Nh&#7919;ng dung d&#7883;ch &#273;ã pha ph&#7843;i &#273;&#432;&#7907;c
b&#7843;o qu&#7843;n trong t&#7911; l&#7841;nh và dùng trong vòng 24 gi&#7901;.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Quá li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Các tri&#7879;u ch&#7913;ng quá li&#7873;u g&#7891;m suy t&#7911;y, bu&#7891;n
nôn, nôn, &#7881;a ch&#7843;y, r&#7909;ng tóc. Không có thu&#7889;c gi&#7843;i
&#273;&#7897;c &#273;&#7863;c hi&#7879;u &#273;&#7889;i v&#7899;i ifosfamid. X&#7917;
trí quá li&#7873;u g&#7891;m các bi&#7879;n pháp h&#7895; tr&#7907; chung
&#273;&#7875; giúp ng&#432;&#7901;i b&#7879;nh ch&#7889;ng &#273;&#7905; l&#7841;i
các tác d&#7909;ng &#273;&#7897;c h&#7841;i có th&#7875; x&#7843;y ra.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Thông tin qui ch&#7871;<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ifosfamid có trong danh m&#7909;c thu&#7889;c thi&#7871;t y&#7871;u Vi&#7879;t
Nam ban hành l&#7847;n th&#7913; t&#432; n&#259;m 1999. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Thu&#7889;c &#273;&#7897;c b&#7843;ng A.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Ifosfamid.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:07:00 GMT -->
</html>
